Sharemaestro Newsreel

Henry Schein Shares Slide as COO, Strategy Chief Among Three Senior Exits in Leadership Overhaul

Henry Schein's shares fell after the company announced a leadership restructuring, with COO Michael Ettinger, Chief Strategy Officer Mark Mlotek, and SVP James Mullins departing by October 30, 2026. This overhaul aims to streamline operations and enhance customer focus, as the company's stock has …

111 Inc (YI) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for 111 Inc (YI), detailing its current risk score, beta value, and various volatility metrics. The company's risk assessment score is 2.72, ranking it 117 out of 155 in the Pharmaceuticals industry. Key data points include maximum drawdown, …

111 Inc (YI) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of 111 Inc (YI), detailing its price momentum score, current trading range, and support/resistance levels. It includes a breakdown of various technical indicators like MACD, RSI, and moving averages, offering "Sell", "Neutral", and "Buy" signals. The analysis also …

Synergy CHC Corp (SNYR) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis for Synergy CHC Corp (SNYR), indicating a current valuation score of 9.10, which ranks 34 out of 155 in the Pharmaceuticals industry. The P/E ratio is noted as -0.11, significantly below its recent high and above its recent …

McKesson Corp. stock underperforms Thursday when compared to competitors

McKesson Corp. (MCK) stock fell by 2.59% to $865.51 on Thursday, underperforming the broader market. This occurred despite an overall positive trading session where the S&P 500 Index rose by 1.66% and the Dow Jones Industrial Average increased by 1.19%. This marks the second …

Henry Schein Restructures Leadership Team to Streamline Operations, Announces Executive Transitions

Henry Schein Inc. is restructuring its leadership by replacing the Executive Management Committee with a new Henry Schein Leadership Team and integrating its global supply chain with its distribution business. This aims to streamline decision-making, enhance operational execution, and improve coordination across the company's …

Henry Schein stock falls as three executives to exit roles

Henry Schein Inc. (NASDAQ:HSIC) shares dropped 1.9% after the company announced a leadership restructuring. Three senior executives, Michael S. Ettinger, Mark E. Mlotek, and James Mullins, will transition out of their current roles on October 30, 2026, but will remain as Senior Advisors. The …

Henry Schein stock falls as three executives to exit roles By Investing.com

Henry Schein Inc (NASDAQ:HSIC) shares fell by 1.9% after the company announced a leadership restructuring. Three senior executives—Michael S. Ettinger, Mark E. Mlotek, and James Mullins—will transition out of their current roles on October 30, 2026, remaining as Senior Advisors. The changes aim to …

Henry Schein Unveils New Leadership Structure

Henry Schein, Inc. announced a new leadership structure, replacing its Executive Management Committee with the Henry Schein Leadership Team (HSLT) and integrating its global supply chain with its global distribution group. This change aims to simplify operations, accelerate decision-making, and enhance collaboration. Additionally, three …

Henry Schein, Inc. Announces Management Changes, Effective October 30, 2026

Henry Schein, Inc. is reorganizing its leadership by forming the Henry Schein Leadership Team (HSLT) to replace its Executive Management Committee and integrating its global supply chain and distribution groups. This restructuring aims to accelerate strategic execution and enhance enterprise collaboration. Effective October 30, …

Michael S. Ettinger and Mark E. Mlotek to Transition to Senior Advisors at Henry Schein

Henry Schein (HSIC) announced that Michael S. Ettinger and Mark E. Mlotek will transition from their Executive Vice President roles to senior advisory roles, effective October 30, 2026. Both individuals will be entitled to payments and benefits under the Company's Executive Severance Plan. The …

Cencora, Inc. (COR) Q2 2024 Earnings Report - Results, Call & Slides

Cencora, Inc. (COR) reported its Q2 2024 earnings, beating the consensus EPS estimate by $1.85 with an actual EPS of $66.27 versus an expected $64.42. However, the company missed revenue expectations, reporting $1.19 trillion against an anticipated $1.23 trillion, despite a 7.81% year-over-year revenue …

YI|111 Inc|Price:3.600|Chg%:-0.250

This article provides a comprehensive stock analysis of 111 Inc (YI) by TradingKey, highlighting its stable fundamentals, high growth potential, and fair valuation. The company operates an integrated online and offline healthcare platform through B2C and B2B segments. Despite weak market performance recently, 111 …

Akso Health Group (AHG) Valuation: PE, PB & Fair Value Analysis

Akso Health Group (AHG) has a current valuation score of 8.45, ranking 161 out of 485 in the Software & IT Services industry. Its P/E ratio is -3.32, which is significantly below its recent high and above its recent low. Key valuation metrics like …

Henry Schein Inc (HSIC) Institutional Confidence

Henry Schein Inc (HSIC) has an institutional shareholding score of 10.00, placing it first in the Healthcare Equipment & Supplies industry. Its institutional shareholding proportion is 109.16%, a slight decrease from the previous quarter. Richard Pzena is the largest institutional shareholder, holding 0.78% of …

Cencora (COR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Cencora (COR) is expected to report a year-over-year increase in earnings and revenues for the quarter ended June 2026. Analysts anticipate quarterly earnings of $4.37 per share, up 9.3%, and revenues of $84.89 billion, up 5.2%. The company's Zacks Earnings ESP of +1.49% combined …

COR|Cencora Inc|Price:318.710|Chg%:-0.870

This article provides a detailed financial overview of Cencora Inc (COR), including its stock price, market cap, P/E ratio, and upcoming earnings date. It presents comprehensive quarterly and annual financial statements, highlighting key indicators like EPS, Revenue, Net Profit, Gross Margin, and Debt to …

Cardinal Health Inc. stock outperforms competitors despite losses on the day

Cardinal Health Inc. (CAH) stock declined by 1.46% to $229.12 on Wednesday, despite outperforming the broader market indices, with the S&P 500 and Dow Jones Industrial Average experiencing larger losses. This fall ended a four-day winning streak for the company's shares.

Cardinal Health (CAH) Could Be 7% Below Fair Value After Its Recent Pullback

Cardinal Health (CAH) has experienced a recent pullback, yet its fair value is estimated to be around $250.53, suggesting it is currently 7.2% undervalued compared to its latest close of $232.51. However, its P/E ratio of 35x is higher than the industry average, pointing …

Henry Schein Number of Employees 2026 | Employee Count & Headcount Data

This article provides an in-depth analysis of Henry Schein, Inc.'s workforce data as of March 2026, sourced from Revelio Labs. It details the company's employee count, which has declined 3.6% since 2023 to 24,981, and highlights hiring trends, geographical distribution, departmental breakdown, and average …

McKesson Corp Lobbyists, 2024

This article details McKesson Corp's lobbying efforts in 2024, including total spending and a comprehensive list of its lobbyists. It highlights that McKesson Corp spent $900K on federal lobbying, with a significant portion of its lobbyists having prior federal government experience, demonstrating the "revolving …

Piper Sandler Adjusts Price Target on Henry Schein to $95 From $91, Maintains Overweight Rating

Piper Sandler has increased its price target for Henry Schein (HSIC) to $95 from $91, while reiterating an Overweight rating on the stock. This adjustment reflects continued analyst confidence in the medical equipment and supplies distributor. Other recent analyst actions also show a trend …

GrowGeneration to Report Second-Quarter Results After Market Close

GrowGeneration (NASDAQ: GRWG) announced it will release its financial results for the second quarter ended June 30, 2026, after market close on Tuesday, August 11, 2026. This will be followed by a live conference call at 4:30 p.m. ET. Investors can access the call …

Cardinal Health, Inc. Revenue Breakdown – MUN:CLH

Cardinal Health, Inc.'s revenue breakdown shows that in the last fiscal year, the company generated €188.95 billion, with the Pharmaceutical and Specialty Solutions segment contributing the most at €173.72 billion. The United States was the largest regional contributor, accounting for €187.60 billion of the …

111 Inc (YI) Financial Health: Profitability & Balance Sheet Analysis

The article provides a financial health analysis of 111 Inc (YI), noting its current financial score is 8.11, ranking 76 out of 155 in the Pharmaceuticals industry with a weak financial status but high operating efficiency. The company experienced a significant year-over-year decrease in …

Synergy CHC Corp (SNYR) Financial Health: Profitability & Balance Sheet Analysis

The financial health of Synergy CHC Corp (SNYR) is currently rated as weak with a score of 7.16, placing it 122nd out of 155 companies in the Pharmaceuticals industry. The company's latest quarterly revenue saw a year-over-year decrease of 32.77%, and its net profit …

McKesson (MCK) Earnings Expected to Grow: Should You Buy?

111 Inc (YI) Balance Sheet

This article provides detailed quarterly and annual balance sheet data for 111 Inc (YI), offering insights into the company's financial health, asset composition, and liability structure. It includes specific figures for cash, assets, liabilities, and shareholders' equity, along with FAQs explaining key balance sheet …

Q1 Earnings Roundup: Henry Schein (NASDAQ:HSIC) And The Rest Of The Dental Equipment & Technology Segment

This article provides an earnings roundup for the dental equipment & technology segment in Q1, focusing on Henry Schein (NASDAQ:HSIC), Envista (NYSE:NVST), Dentsply Sirona (NASDAQ:XRAY), and Align Technology (NASDAQ:ALGN). It details their revenue performance against analyst expectations, highlighting Henry Schein as the weakest performer …

Cosmos Health Advances Its Technology-Driven Transformation

Cosmos Health Inc. is developing an AI-enabled subscription platform for its consumer health products, marking a significant step in its technology-driven transformation. The platform will cater to both B2C and B2B channels, offering personalized recommendations based on customer health goals and supporting employee wellness …

Henry Schein Prepares to Report Q2 Earnings: What's in the Cards?

Henry Schein, Inc. (HSIC) is set to announce its second-quarter 2026 earnings on August 4th. Analysts project revenues of $3.36 billion and EPS of $1.22, suggesting year-over-year increases of 3.8% and 10.9%, respectively. The company's performance is expected to be driven by solid dental …

UBS Lifts Price Target on Henry Schein to $89 From $85, Maintains Neutral Rating

UBS has increased its price target for Henry Schein from $85 to $89, while reiterating a Neutral rating on the stock. This adjustment reflects a modest upgrade in the outlook for the dental and medical product distributor. Henry Schein specializes in healthcare products and …

NOOR Collagen Repeat Rate Above 60% as Cosmos Health Develops AI Platform

Cosmos Health is actively developing an AI-enabled digital subscription platform for its consumer health products, targeting both B2C and B2B channels. The initiative builds on the success of its U.S. NOOR Collagen subscription model, which boasts an early repeat purchase rate of over 60%. …

McKesson Corporation (MCK) Stock Analysis: Evaluating The 12.44% Potential Upside

This article provides an analysis of McKesson Corporation (MCK), a healthcare titan with a market capitalization of $98.45 billion. The analysis highlights its financial stability, revenue growth, and strong cash generation, alongside a modest dividend yield. With positive analyst ratings and a potential upside …

Akso Health Group (AHG) Institutional Confidence

Akso Health Group (AHG) has an institutional shareholding score of 3.00, placing it 283rd out of 485 companies in the Software & IT Services industry. The institutional shareholding proportion is 0.02%, representing a significant quarter-over-quarter decrease. James Simons is identified as the largest institutional …

111 Inc (YI) Institutional Confidence

This article analyzes the institutional confidence in 111 Inc (YI), a Pharmaceuticals industry company. The current institutional shareholding score is 3.00, placing it 92nd out of 155 in its industry. Institutional shareholding proportion increased by 446.56% quarter-over-quarter to 6.89%, with James Simons being the …